Control of experimental inflammatory bowel disease by regulatory T cells

American Journal of Respiratory and Critical Care Medicine

Volumn 162, Issue 4 II, 2000, Pages

  Asseman, C ^a   Fowler, S ^a   Powrie, F ^a  

^a UNIVERSITY OF OXFORD   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

GAMMA INTERFERON ANTIBODY; INTERLEUKIN 10; MONOCLONAL ANTIBODY; TRANSFORMING GROWTH FACTOR BETA; TUMOR NECROSIS FACTOR ALPHA;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; CELL DIFFERENTIATION; CELL TRANSFER; CONFERENCE PAPER; ENTERITIS; ENTEROCOLITIS; HELPER CELL; IMMUNOREGULATION; IMMUNOSUPPRESSIVE TREATMENT; MOUSE; NONHUMAN; PRIORITY JOURNAL; T LYMPHOCYTE; T LYMPHOCYTE ACTIVATION;

EID: 0033763306     PISSN: 1073449X     EISSN: None     Source Type: Journal    
DOI: 10.1164/ajrccm.162.supplement_3.15tac9     Document Type: Conference Paper

References (43)

1. Control of immune pathology by regulatory T cells
2. Experimental models of inflammatory bowel disease
3. Genetic and spontaneous models of inflammatory bowel disease in rodents: Evidence for abnormalities in mucosal immune regulation
4. CD4+ T cells that express high levels of CD45RB induce wasting disease when transferred into congenic severe combined immuno-deficient mice: Disease development is prevented by cotransfer of purified. CD4+ T cells
5. Phenotypically distinct subsets of CD4+ T cells induce or protect from chronic intestinal inflammation in C. B-17 scid mice
6. Inhibition of Th1 responses prevents inflammatory bowel disease in scid mice reconstituted with CD45RBhi CD4+ T cells
7. A critical role for transforming growth factor-beta but not interleukin 4 in the suppression of T helper type 1-mediated colitis by CD45RB-(low) CD4+ T cells
8. Interleukin-10-deficient mice develop chronic enterocolitis
9. Enterocolitis and colon cancer in interleukin-10-deficient mice are associated with aberrant cytokine production and CD4(+) TH1-like responses
10. Altered immune responses in interleukin 10 transgenic mice
11. An essential role for interleukin 10 in the function of regulatory T cells that inhibit intestinal inflammation
12. An ancient system of host defense
13. Reciprocal IFN-gamma and TGF-beta responses regulate the occurrence of mucosal inflammation
14. Helicobacter hepaticus triggers colitis in specific-pathogen-free interleukin-10 (IL-10)-deficient mice through an IL-12- and gamma interferon-dependent mechanism
15. CD4+ T cell down-regulation in human intestinal mucosa: Evidence for intestinal tolerance to luminal bacterial antigens
16. Blocking CD40-CD154 and CD80/CD86-CD28 interactions during primary allogeneic stimulation results in T cell anergy and high IL-10 production
17. Co-stimulation of T cells results in distinct IL-10 and TNF-alpha cytokine profiles dependent on binding to ICAM-1, ICAM-2 or ICAM-3
18. Interleukin-10
19. Transforming growth factor beta: The good, the bad, and the ugly
20. IL-10 acts on the antigen-presenting cell to inhibit cytokine production by Th1 cells
21. IL-10 inhibits mitogen-induced T cell proliferation by selectively inhibiting macrophage costimulatory function
22. Enhanced Th1 activity and development of chronic enterocolitis in mice devoid of Stat3 in macrophages and neutrophils
23. Targeted disruption of the mouse transforming growth factor-beta 1 gene results in multifocal inflammatory disease
24. TGF-beta enhances macrophage ability to produce IL-10 in normal and tumor-bearing mice
25. Infectious immunological tolerance
26. 'Infectious' transplantation tolerance
27. Interleukin-10 induces a long-term antigen-specific anergic state in human CD4+ T cells
28. CD38+ CD45RB(low) CD4+ T cells: A population of T cells with immune regulatory activities in vitro
29. CD4+CD25+ immunoregulatory T cells suppress polyclonal T cell activation in vitro by inhibiting interleukin 2 production
30. Regulatory CD4 T cells: Expression of IL-2R alpha chain, resistance to clonal deletion and IL-2 dependency
31. Immunologic self-tolerance maintained by CD25+CD4+ naturally anergic and suppressive T cells: Induction of autoimmune disease by breaking their anergic/suppressive state
32. Engagement of cytotoxic T lymphocyte-associated antigen 4 (CTLA-4) induces transforming growth factor beta (TGF-beta) production by murine CD(+) T cells
33. Transforming growth factor beta (TGFbeta)-dependent inhibition of T helper cell 2 (Th2)-induced autoimmunity by self-major histocompatibility complex (MHC) class II-specific, regulatory CD4(+) T cell lines
34. Regulatory T cells in the control of autoimmunity: The essential role of transforming growth factor beta and interleukin 4 in the prevention of autoimmune thyroiditis in rats by peripheral CD4(+)CD45RC- cells and CD4(+)CD8(-) thymocytes
35. Alpha/beta-T cell receptor (TCR)+ CD4-CD8- (NKT) thymocytes prevent insulin-dependent diabetes mellitus in nonobese diabetic (NOD)/Lt mice by the influence of interleukin (IL)-4 and/or IL-10
36. Autoimmune disease as a consequence of developmental abnormality of a T cell subpopulation
37. CD4+CD25+ T cells inhibit both the induction and effector function of autoreactive T cells and represent a unique lineage of immunoregulatory cells
38. In situ immune response in gut-associated lymphoid tissue (GALT) following oral antigen in TCR-transgenic mice
39. Oral tolerance: Immune mechanisms and treatment of autoimmune diseases
40. Regulatory T cell clones induced by oral tolerance: Suppression of autoimmune encephalomyelitis
41. IL-4 and IL-10 are both required for the induction of oral tolerance
42. Peptide-induced T cell regulation of experimental autoimmune encephalomyelitis: A role for IL-10
43. A CD4+ T-cell subset inhibits antigen-specific T-cell responses and prevents colitis